Morphine Added to Ropivacaine for FICB for Postoperative Analgesia
NCT ID: NCT03875274
Last Updated: 2023-03-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
70 participants
INTERVENTIONAL
2017-04-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture
NCT00529425
Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture
NCT05920642
The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty
NCT01261897
Multimodal Analgesia for the Reduction of Postoperative Opioid Consumption
NCT03817034
Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type
NCT01119209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine group
Ropivacaine 0.375% 20 ml + Normal saline 2 ml via FICB
Ropivacaine, Saline
Normal saline added to ropivacaine for fascia iliaca compartment block
Ropivacaine and morphine group
Ropivacaine 0.375% 20 ml + Morphine 2 ml via FICB
Ropivacaine, Morphine
Morphine added to ropivacaine for fascia iliaca compartment block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine, Morphine
Morphine added to ropivacaine for fascia iliaca compartment block
Ropivacaine, Saline
Normal saline added to ropivacaine for fascia iliaca compartment block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age group (18-65 years)
* ASA physical status I and II
Exclusion Criteria
* Other painful co-morbidities (neuropathies)
* Allergy or any contraindication to study medication
* Psychiatric disorder
* Coagulopathy
* Infection at the site of the block
* Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
B.P. Koirala Institute of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pankaj Baral
Junior Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BPKIHS
Dharān, Sunsari, Nepal
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRC/0832/016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.